Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (151-160 of 337) with videos related to

Pageof 34
Sort By:
Antiviral Therapy|August 6, 2011
The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentrationWouter F W Bierman, Marit G A van Vonderen, Agnes I Veldkamp, et al.
American Journal of Obstetrics and Gynecology|September 3, 2020
Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivoJolien J M Freriksen, Miriam Meijerhof, Joris van Drongelen, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.
Therapeutic Drug Monitoring|December 31, 2010
Adherence to HIV therapeutic drug monitoring guidelines in The NetherlandsMatthijs van Luin, Ferdinand W Wit, Colette Smit, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) StudyJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2009
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agentsRoger J M Brüggemann, Jan-Willem C Alffenaar, Nicole M A Blijlevens, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic reviewTom G Jacobs, Elin M Svensson, Victor Musiime, et al.
Antiviral Therapy|August 22, 2012
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patientsReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
Biomedical Chromatography : BMC|August 13, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasmaEsther M Hollander, Nachel M C Zimmerman, Berber Piet, et al.
Pageof 34

Showing results (151-160 of 337) with videos related to

Sort By:
Pageof 34
Antiviral Therapy|August 6, 2011
The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentrationWouter F W Bierman, Marit G A van Vonderen, Agnes I Veldkamp, et al.
American Journal of Obstetrics and Gynecology|September 3, 2020
Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivoJolien J M Freriksen, Miriam Meijerhof, Joris van Drongelen, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.
Therapeutic Drug Monitoring|December 31, 2010
Adherence to HIV therapeutic drug monitoring guidelines in The NetherlandsMatthijs van Luin, Ferdinand W Wit, Colette Smit, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) StudyJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2009
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agentsRoger J M Brüggemann, Jan-Willem C Alffenaar, Nicole M A Blijlevens, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic reviewTom G Jacobs, Elin M Svensson, Victor Musiime, et al.
Antiviral Therapy|August 22, 2012
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patientsReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
Biomedical Chromatography : BMC|August 13, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasmaEsther M Hollander, Nachel M C Zimmerman, Berber Piet, et al.
Pageof 34